Role of calpain in skeletal-muscle protein degradation

被引:260
作者
Huang, J [1 ]
Forsberg, NE [1 ]
机构
[1] Oregon State Univ, Dept Anim Sci, Corvallis, OR 97331 USA
关键词
fodrin; nebulin;
D O I
10.1073/pnas.95.21.12100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although protein degradation is enhanced in muscle-wasting conditions and limits the rate of muscle growth in domestic animals, the proteolytic system responsible for degrading myofibrillar proteins in skeletal muscle is not well defined. The goals of this study were to evaluate the roles of the calpains (calcium-activated cysteine proteases) in mediating muscle protein degradation and the extent to which these proteases participate in protein turnover in muscle. Two strategies to regulate intracellular calpain activities were developed: overexpression of dominant-negative m-calpain and overexpression of calpastatin inhibitory domain. To express these constructs, L8 myoblast cell lines were transfected with LacSwitch plasmids, which allowed for isopropyl beta-D-thiogalactoside-dependent expression of the gene of interest. Inhibition of calpain stabilized fodrin, a well characterized calpain substrate. Under conditions of accelerated degradation (serum withdrawal), inhibition of m-calpain reduced protein degradation by 30%, whereas calpastatin inhibitory domain expression reduced degradation by 63%. Inhibition of calpain also stabilized nebulin. These observations indicate that calpains play key roles in the disassembly of sarcomeric proteins. Inhibition of calpain activity may have therapeutic value in treatment of muscle-wasting conditions and may enhance muscle growth in domestic animals.
引用
收藏
页码:12100 / 12105
页数:6
相关论文
共 56 条
  • [1] DYSTROPHIN AND THE MEMBRANE HYPOTHESIS OF MUSCULAR-DYSTROPHY
    ARAHATA, K
    SUGITA, H
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (11) : 437 - 439
  • [2] EFFECT OF FASTING ON CALCIUM ACTIVATED PROTEASE IN RAT SKELETAL-MUSCLE
    ARAKAWA, N
    TAKASHIMA, M
    KURATA, T
    FUJIMAKI, M
    [J]. AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1983, 47 (07): : 1517 - 1522
  • [3] Ausubel F., 1990, CURRENT PROTOCOLS MO
  • [4] AZAMZA JL, 1979, BIOCHEM J, V183, P339
  • [5] EFFECT OF BETA-AGONISTS ON EXPRESSION OF CALPAIN AND CALPASTATIN ACTIVITY IN SKELETAL-MUSCLE
    BARDSLEY, RG
    ALLCOCK, SMJ
    DAWSON, JM
    DUMELOW, NW
    HIGGINS, JA
    LASSLETT, YV
    LOCKLEY, AK
    PARR, T
    BUTTERY, PJ
    [J]. BIOCHIMIE, 1992, 74 (03) : 267 - 273
  • [6] BIRD JWC, 1980, FED PROC, V39, P20
  • [7] FODRIN DEGRADATION AND SUBCELLULAR-DISTRIBUTION OF CALPAINS AFTER NEONATAL RAT CEREBRAL HYPOXIC-ISCHEMIA
    BLOMGREN, K
    KAWASHIMA, S
    SAIDO, TC
    KARLSSON, JO
    ELMERED, A
    HAGBERG, H
    [J]. BRAIN RESEARCH, 1995, 684 (02) : 143 - 149
  • [8] CA2+-SPECIFIC REMOVAL OF Z LINES FROM RABBIT SKELETAL-MUSCLE
    BUSCH, WA
    SUZUKI, A
    STROMER, MH
    GOLL, DE
    [J]. JOURNAL OF CELL BIOLOGY, 1972, 52 (02) : 367 - &
  • [9] DOMAIN-STRUCTURE OF CALPAIN - MAPPING THE BINDING-SITE FOR CALPASTATIN
    CROALL, DE
    MCGRODY, KS
    [J]. BIOCHEMISTRY, 1994, 33 (45) : 13223 - 13230
  • [10] Dahlmann B, 1989, Contrib Nephrol, V73, P127